Литература
1. World Health Organization. Estimates for 2000-2015. Cause-specific mortality. (date of access May 11, 2017). URL: http://www.who.int/healthinfo/global_burden_ disease/estimates/en/index1.html
2. Koton S., Sang Y., Schneider A.L.C., Rosamond W.D. et al. Trends in Stroke incidence rates in older us adults: an update from the Atherosclerosis Risk in Communities (ARIC) Cohort Study // JAMA Neurol. 2019 Sep 30. URL: https://pubmed.ncbi.nlm.nih.gov/31566685-trends-in-stroke-incidence-rates-in-older-us-adults-an-update-from-the-atherosclerosis-risk-in-communities-aric-cohort-study/. doi: 10.1001/jamaneurol.2019.3258
3. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specifc mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 // Lancet. 2016. Vol. 388. P. 1459-1544.
4. Shah R., Wilkins E., Nichols M. et al. Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data // Eur. Heart J. 2019. Vol. 40. P. 755-764.
5. Wilkins E., Wilson L., Wickramasinghe K. et al. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network, 2017.
6. Widimsky P., Doehner W., Diener H.C. et al.; on behalf of the ESC Council on Stroke. The role of cardiologists in stroke prevention and treatment: Position paper of the European Society of Cardiology Council on Stroke // Eur. Heart J. 2018. Vol. 39. P. 1567-1573
7. Adams H.P. Jr, Bendixen B.H., Kappelle L.J. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment // Stroke. 1993. Vol. 24. P. 35-41.
8. Mozaffarian D., Benjamin E.J., Go A.S. et al. Heart Disease and Stroke Statistics - 2016 Update: a report from the American Heart Association // Circulation. 2016. Vol. 133, N 4. P. e38-e60. URL: https://pubmed.ncbi.nlm.nih.gov/26673558-heart-disease-and-stroke-statistics-2016-update-a-report-from-the-american-heart-association/. doi: 10.1161/CIR.0000000000000350
9. Fang M.C., Coca Perraillon M., Ghosh K. et al. Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008 // Am.J. Med. 2014. Vol. 127, N 7. P. 608-615. URL: https://pubmed.ncbi.nlm.nih.gov/24680794-trends-in-stroke-rates-risk-and-outcomes-in-the-united-states-1988-to-2008/. doi: 10.1016/j.amjmed.2014.03.017
10. Guzik A., Bushnell C. Stroke epidemiology and risk factor management // Continuum (Minneap Minn). 2017. Vol. 23, N 1. Cerebrovascular Disease.P. 15-39. URL: https://www.researchgate.net/publication/313581702_Stroke_Epidemiology_and_Risk_Factor_Management. doi: 10.1212/CON.0000000000000416
11. Wilkins E., Wilson L., Wickramasinghe K. et al. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network, 2017. URL: https://journals.sagepub.com/doi/10.1177/2047487319873460. doi: 10.1177/2047487319873460
12. Doehner W., Mazighi M., Hofmann B.M., Lautsch D. et al. Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: a consensus report from the European Society of Cardiology Cardiovascular Round Table // Eur.J. Prev. Cardiol. 2019. Article ID 2 0474 873198 73 4 6 0. URL: https://pubmed.ncbi.nlm.nih.gov/31569966. doi: 10.1177/2047487319873460
13. Ferrieres J., Lautsch D., Ambegaonkar B.M. et al. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study // Int.J. Cardiol. 2018. Vol. 270. P. 21-27. URL: https://pubmed.ncbi.nlm.nih.gov/29934227-use-of-guideline-recommended-management-in-established-coronary-heart-disease-in-the-observational-dysis-ii-study/. doi: 10.1016/j.ijcard.2018.06.008
14. Zeller T., Schnabel R.B., Appelbaum S. et al. Low testosterone levels are predictive for incident atrial fibrillation and ischaemic stroke in men, but protective in women - results from the FINRISK study // Eur.J. Prev. Cardiol. 2018. Vol. 25. P. 1133-1139.
15. O’Donnell M.J., Chin S.L., Rangarajan S. et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study // Lancet. 2016. Vol. 388. P. 761-775.
16. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies // BMJ. 2009. Vol. 338. Article ID b1665. URL: https://www.bmj.com/content/338/bmj.b1665. doi: 10.1136/bmj.b1665
17. Chobanian A.V. Guidelines for the management of hypertension // Med. Clin. North Am. 2017. Vol. 101, N 1. P. 219-227.
18. Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH guidelines for the management of arterial hypertension // Eur. Heart J. 2018. Vol. 39. P. 3021-3104.
19. Золотовская И.А., Дупляков Д.В., Зюзина Т.В., Давыдкин И.Л. Депрескрайбинг антигипертензивной терапии у пациентов с артериальной гипертензией старше 60 лет (результаты наблюдательной программы "ГРАНАТ") // Артериальная гипертензия. 2019. Т. 25., № 3. С. 267-277.
20. SPRINT Research Group; Wright J.T. Jr, Williamson J.D. et al. A randomized trial of intensive versus standard blood-pressure control // N. Engl.J. Med. 2015. Vol. 373, N 22. P. 2103-2116. URL: https://pubmed.ncbi.nlm.nih.gov/26551272-a-randomized-trial-of-intensive-versus-standard-blood-pressure-control/. doi: 10.1056/NEJMoa1511939
21. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report // JAMA. 2003. Vol. 289, N 19. P. 2560-2572.
22. Yang J., Lu F., Zhang C., Liu Z. et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007 // Hypertens. Res. 2010. Vol. 33, N 4. P. 331-337.
23. Sit J.W., Sijian L., Wong E.M., Yanling Z. et al. Prevalence and risk factors associated with prehypertension: identification of foci for primary prevention of hypertension // J. Cardiovasc. Nurs. 2010. Vol. 25, N 6. P. 461-469.
24. Erem C., Hacihasanoglu A., Kocak M., Deger O. et al. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study // J. Public Health (Oxf.). 2009. Vol. 31, N 1. P. 47-58.
25. Isezuo S.A., Sabir A.A., Ohwovorilole A.E., Fasanmade O.A. Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria // J. Hum. Hypertens. 2011. Vol. 25, N 4. P. 224-230.
26. Agyemang C., Owusu-Dabo E. Prehypertension in the Ashanti region of Ghana, West Africa: an opportunity for early prevention of clinical hypertension // Public Health. 2008. Vol. 122, N 1. P. 19-24.
27. Chrysohoou C., Pitsavos C., Panagiotakos D.B., Skoumas J. et al. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study // Am.J. Hypertens. 2004. Vol. 17, N 7. P. 568-573.
References
1. World Health Organization. Estimates for 2000-2015. Cause-specific mortality. URL: http://www.who.int/healthinfo/global_burden_ disease/estimates/en/index1.html (date of access May 11, 2017)
2. Koton S., Sang Y., Schneider A.L.C., Rosamond W.D., et al. Trends in Stroke incidence rates in older us adults: an update from the Atherosclerosis Risk in Communities (ARIC) Cohort Study. JAMA Neurol. 2019 Sep 30. doi: 10.1001/jamaneurol. 2019.3258. URL: https://pubmed.ncbi.nlm.nih.gov/31566685-trends-in-stroke-incidence-rates-in-older-us-adults-an-update-from-the-atherosclerosis-risk-in-communities-aric-cohort-study/. doi: 10.1001/jamaneurol.2019.3258
3. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specifc mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388: 1459-544.
4. Shah R., Wilkins E., Nichols M., et al. Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data. Eur Heart J. 2019; 40: 755-64.
5. Wilkins E., Wilson L., Wickramasinghe K., et al. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network, 2017.
6. Widimsky P., Doehner W., Diener H.C., et al.; on behalf of the ESC Council on Stroke. The role of cardiologists in stroke prevention and treatment: Position paper of the European Society of Cardiology Council on Stroke. Eur Heart J. 2018; 39: 1567-73.
7. Adams H.P. Jr, Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24: 35-41.
8. Mozaffarian D., Benjamin E.J., Go A.S., et al. Heart Disease and Stroke Statistics - 2016 Update: a report from the American Heart Association. Circulation. 2016; 133 (4): e38-e60. doi: 10.1161/ CIR.0000000000000350. URL: https://pubmed.ncbi.nlm.nih.gov/26673558-heart-disease-and-stroke-statistics-2016-update-a-report-from-the-american-heart-association/. doi: 10.1161/CIR.0000000000000350
9. Fang M.C., Coca Perraillon M., Ghosh K., et al. Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. Am J Med. 2014; 127 (7): 608-15. doi: 10.1016/j.amjmed.2014.03.017. URL: https://pubmed.ncbi.nlm.nih.gov/24680794-trends-in-stroke-rates-risk-and-outcomes-in-the-united-states-1988-to-2008/. doi: 10.1016/j.amjmed.2014.03.017
10. Guzik A., Bushnell C. Stroke epidemiology and risk factor management. Continuum (Minneap Minn). 2017; 23 (1, Cerebrovascular Disease): 15-39. doi: 10.1212/CON.0000000000000416. URL: https://www.researchgate.net/publication/313581702_Stroke_Epidemiology_and_Risk_Factor_Management. doi: 10.1212/CON.0000000000000416
11. Wilkins E., Wilson L., Wickramasinghe K., et al. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network, 2017.12. Doehner W., Mazighi M., Hofmann B.M., Lautsch D., et al. Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: a consensus report from the European Society of Cardiology Cardiovascular Round Table. Eur J Prev Cardiol. 2019: 20474 87319 87 3 4 60. URL: https://journals.sagepub.com/doi/10.1177/2047487319873460. doi: 10.1177/2047487319873460
12. Doehner W., Mazighi M., Hofmann B.M., Lautsch D. et al. Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: a consensus report from the European Society of Cardiology Cardiovascular Round Table // Eur.J. Prev. Cardiol. 2019. Article ID 2 0474 873198 73 4 6 0. URL: https://pubmed.ncbi.nlm.nih.gov/31569966. doi: 10.1177/2047487319873460
13. Ferrieres J., Lautsch D., Ambegaonkar B.M., et al. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study. Int J Cardiol. 2018; 270: 21-7. doi: 10.1016/j.ijcard.2018.06.008
13. Ferrieres J., Lautsch D., Ambegaonkar B.M. et al. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study // Int.J. Cardiol. 2018. Vol. 270. P. 21-27. URL: https://pubmed.ncbi.nlm.nih.gov/29934227-use-of-guideline-recommended-management-in-established-coronary-heart-disease-in-the-observational-dysis-ii-study/. doi: 10.1016/j.ijcard.2018.06.008
14. Zeller T., Schnabel R.B., Appelbaum S., et al. Low testosterone levels are predictive for incident atrial fibrillation and ischaemic stroke in men, but protective in women - results from the FINRISK study. Eur J Prev Cardiol. 2018; 25: 1133-9.
15. O’Donnell M.J., Chin S.L., Rangarajan S., et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388: 761-75.
16. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665. URL: https://www.bmj.com/content/338/bmj.b1665. doi: 10.1136/bmj.b1665
17. Chobanian A.V. Guidelines for the management of hypertension. Med Clin North Am. 2017; 101 (1): 219-27.
18. Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39: 3021-104.
19. Zolotovskaya I.A., Duplyakov D.V., Zyuzina T.V., Davydkin I.L. Deprescribing of hypotensive therapy in hypertensive patients over 60 years (results of the program "GRANAT"). Arterial’naya gipertenziya [Arterial Hypertension]. 2019; 25 (3): 267-77. (in Russian)
20. SPRINT Research Group; Wright J.T. Jr, Williamson J.D., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373 (22): 2103-2116. URL: https://pubmed.ncbi.nlm.nih.gov/26551272-a-randomized-trial-of-intensive-versus-standard-blood-pressure-control/. doi: 10.1056/NEJMoa1511939
21. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289 (19): 2560-72.
22. Yang J., Lu F., Zhang C., Liu Z., et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res. 2010; 33 (4): 331-7.
23. Sit J.W., Sijian L., Wong E.M., Yanling Z., et al. Prevalence and risk factors associated with prehypertension: identification of foci for primary prevention of hypertension. J. Cardiovasc. Nurs. 2010; 25 (6): 461-9.
24. Erem C., Hacihasanoglu A., Kocak M., Deger O., et al. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf). 2009; 31 (1): 47-58.
25. Isezuo S.A., Sabir A.A., Ohwovorilole A.E., Fasanmade O.A. Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria. J Hum Hypertens. 2011; 25 (4): 224-30.
26. Agyemang C., Owusu-Dabo E. Prehypertension in the Ashanti region of Ghana, West Africa: an opportunity for early prevention of clinical hypertension. Public Health. 2008; 122 (1): 19-24.
27. Chrysohoou C., Pitsavos C., Panagiotakos D.B., Skoumas J., et al. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study. Am J Hypertens. 2004; 17 (7): 568-73.